Eribulin and Lenvatinib in Advanced Solid Tumors
Clinical trial NCT02640508 · COMPLETED
Trial details
- NCT number
- NCT02640508
- Sponsor
- Virginia G. Kaklamani
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2020-11-24
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.